What is HK Surgical?
Founded in 1998 by Dr. Jeffrey Klein, HK Surgical has established itself as a critical provider of specialized equipment for procedures involving Tumescent Local Anesthesia, most notably liposuction and varicose vein ablation. The company is widely recognized for the development of the Klein Pump, a cornerstone technology that has fundamentally altered the safety and efficacy profiles of outpatient surgical procedures. Beyond its core hardware, the firm maintains a robust portfolio of cannulas and post-operative garments, serving a diverse clientele of medical professionals and surgical facilities. By integrating high-quality manufacturing with direct clinical support, HK Surgical bridges the gap between complex surgical requirements and practical, patient-centric outcomes.
How much funding has HK Surgical raised?
HK Surgical has raised a total of $243K across 1 funding round:
Debt
$243K
Debt (2021): $243K with participation from PPP
Key Investors in HK Surgical
PPP
Public-Private Partnership
What's next for HK Surgical?
With this late-stage capital, HK Surgical is well-positioned to scale its operational footprint and deepen its penetration into the global aesthetic surgery market. The strategic deployment of these funds will likely focus on expanding the company's R&D pipeline to refine existing instrumentation and potentially explore new applications for its proprietary pump technology. As the demand for minimally invasive cosmetic procedures continues to rise, the firm is poised to leverage its established reputation to capture additional market share. Future growth initiatives will likely prioritize supply chain optimization and the enhancement of its digital distribution channels, ensuring that medical practitioners worldwide have seamless access to the specialized tools required for high-precision surgical interventions.
See full HK Surgical company page
